清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody–drug conjugates

帕妥珠单抗 点突变 错义突变 突变 药物设计 突变体 化学 癌症研究 遗传学 生物 生物化学 曲妥珠单抗 癌症 基因 乳腺癌
作者
Xuefei Bai,Lingyi Xu,Zhe Wang,Xinlei Zhuang,Jiangtao Ning,Yanping Sun,Haibin Wang,Yugang Guo,Yingchun Xu,Jiangtao Guo,Shuqing Chen,Liqiang Pan
出处
期刊:Proceedings of the National Academy of Sciences of the United States of America [National Academy of Sciences]
卷期号:122 (1)
标识
DOI:10.1073/pnas.2413686122
摘要

Recurrent missense mutations in the human epidermal growth factor receptor 2 (HER2) have been identified across various human cancers. Among these mutations, the active S310F mutation in the HER2 extracellular domain stands out as not only oncogenic but also confers resistance to pertuzumab, an antibody drug widely used in clinical cancer therapy, by impeding its binding. In this study, we have successfully employed computational-aided rational design to undertake directed evolution of pertuzumab, resulting in the creation of an evolved pertuzumab variant named Ptz-SA. This variant, with only two mutations (T30S/D31A) located on its heavy chain, effectively reinstates binding to the mutated antigen, at the expense of a 35-fold reduction in binding affinity to HER2 (S310F) compared to the wild-type pair. Subsequently, Ptz-SA demonstrates potent killing capacity through antigen-dependent cytotoxicity. Moreover, upon engineering Ptz-SA into antibody–drug conjugates, such as Ptz-SA-MMAE, it manifests notable in vitro and in vivo antitumor efficacy by efficiently delivering cytotoxic payload into tumor cells expressing HER2 (S310F). Cryoelectron microscopy studies elucidate the molecular mechanism underlying the restored binding ability of Ptz-SA toward the S310F mutation. The steric hindrance induced by the S310F mutation is efficiently circumvented by the T30S and D31A mutations, which provides adequate space to accommodate the larger phenylalanine. Additionally, Ptz-SA also exhibits binding capacity to HER2 (S310Y), another mutation occurring at the S310 site of HER2 with high frequency. The computational-aided evolution of pertuzumab provides an alternative strategy for overcoming point mutation-mediated resistance to therapeutic antibodies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
ww完成签到,获得积分10
20秒前
斯文败类应助ceeray23采纳,获得20
29秒前
机智秋莲发布了新的文献求助20
31秒前
ChatGPT完成签到,获得积分10
39秒前
所所应助科研通管家采纳,获得10
47秒前
47秒前
55秒前
ceeray23发布了新的文献求助20
1分钟前
海阔天空完成签到 ,获得积分10
1分钟前
zys发布了新的文献求助10
1分钟前
ffdhdh应助LYZSh采纳,获得10
1分钟前
2分钟前
机智秋莲完成签到,获得积分20
2分钟前
欣欣子完成签到 ,获得积分10
2分钟前
apt完成签到 ,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
3分钟前
董可以发布了新的文献求助10
3分钟前
Orange应助董可以采纳,获得10
3分钟前
飞翔的企鹅完成签到,获得积分10
4分钟前
4分钟前
董可以发布了新的文献求助10
4分钟前
LYZSh发布了新的文献求助10
4分钟前
彭于晏应助董可以采纳,获得10
4分钟前
科研通AI2S应助科研通管家采纳,获得10
4分钟前
LYZSh完成签到,获得积分10
4分钟前
鳗鱼飞松完成签到 ,获得积分20
4分钟前
widesky777完成签到 ,获得积分0
5分钟前
霜二完成签到 ,获得积分10
5分钟前
xiaofeixia完成签到 ,获得积分10
5分钟前
ys完成签到 ,获得积分10
6分钟前
grace完成签到,获得积分10
6分钟前
ll完成签到,获得积分20
6分钟前
852应助ll采纳,获得10
6分钟前
mojito完成签到 ,获得积分10
6分钟前
muriel完成签到,获得积分10
6分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
奥利奥利奥完成签到 ,获得积分10
7分钟前
7分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990543
求助须知:如何正确求助?哪些是违规求助? 3532220
关于积分的说明 11256532
捐赠科研通 3271057
什么是DOI,文献DOI怎么找? 1805207
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234